Released on: June 18, 2008, 11:04 am

Press Release Author: GTC Bio

Industry: Biotech

Press Release Summary: Gavin Choy, Vice President of Clinical Research Operations at
SuperGen, Inc. will be speaking at GTCbio's Global Clinical Trial Operations
conference on September 25-26, 2008 in San Diego, CA. Dr. Mayne will give a
presentation entitled ADME in Phase 1 Clinical Trials.

Press Release Body: Dr. Choy's presentation at the conference will highlight the
importance of pre-clinical ADME for Phase 1 studies and provide the importance of
Phase 1 ADME for further development. He will also offer details on dose
adjustments in special populations, along with Drug-Drug interactions.

The Global Clinical Trial Operations conference brings together leaders, directors,
vice presidents, heads, managers, supervisors, and CROs from all over the world to
collaborate and discuss the latest developments in clinical trial operations and
logistics and covers clinical trials in emerging markets, first-in-man clinical
trials, pediatric clinical trials, material storage, distribution, site selection,
patient recruitment and retention, technology in clinical trials and case studies of
running global clinical trials.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.

ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.


Web Site: http://gtcbio.com/conferenceDetails.aspx?id=127

Contact Details: 434 W. Foothill Blvd.
Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 256-6460
email: nina.tran@gtcbio.com